[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01GA01, streptomycin, Baricitinib may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Baricitinib.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Baricitinib.]
[L04AA27, fingolimod, Baricitinib may increase the immunosuppressive activities of Fingolimod.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01CG01, sulbactam, Sulbactam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Baricitinib.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01BB02, mercaptopurine, The serum concentration of Baricitinib can be increased when it is combined with Mercaptopurine.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Teniposide is combined with Baricitinib.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Dabigatran etexilate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G03BA03, testosterone, The excretion of Baricitinib can be increased when combined with Testosterone.]
[S03AA02, tetracycline, The serum concentration of Baricitinib can be increased when it is combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Thalidomide is combined with Baricitinib.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Eribulin is combined with Baricitinib.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Thiotepa is combined with Baricitinib.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Baricitinib.]
[G04BE06, moxisylyte, Moxisylyte may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05AL03, tiapride, Baricitinib may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AA12, tobramycin, Baricitinib may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Baricitinib.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Baricitinib.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Triethylenetetramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Baricitinib.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Baricitinib is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Baricitinib.]
[A03AA05, trimebutine, Trimebutine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01FA08, troleandomycin, The metabolism of Baricitinib can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Baricitinib.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Belimumab is combined with Baricitinib.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R02AA14, oxyquinoline, Oxyquinoline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Baricitinib can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Baricitinib can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Baricitinib can be decreased when combined with Telaprevir.]
[S01AA28, vancomycin, Baricitinib may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Belatacept is combined with Baricitinib.]
[N03AX21, ezogabine, Ezogabine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B01AF01, rivaroxaban, Rivaroxaban may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C08DA01, verapamil, The metabolism of Baricitinib can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Baricitinib can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Vinblastine is combined with Baricitinib.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Vincristine is combined with Baricitinib.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Baricitinib.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B01AA03, warfarin, Baricitinib may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The serum concentration of Baricitinib can be increased when it is combined with Zidovudine.]
[J05AE02, indinavir, The metabolism of Baricitinib can be decreased when combined with Indinavir.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Baricitinib.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Baricitinib can be decreased when combined with Crizotinib.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05AE04, ziprasidone, The metabolism of Baricitinib can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Deferiprone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Baricitinib.]
[N02BA01, aspirin, The serum concentration of Baricitinib can be increased when it is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Baricitinib.]
[G04BD07, tolterodine, Tolterodine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Baricitinib.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Baricitinib.]
[J02AC03, voriconazole, The metabolism of Baricitinib can be decreased when combined with Voriconazole.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Baricitinib is combined with Prednylidene.]
[B03XA04, peginesatide, Peginesatide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Azacitidine is combined with Baricitinib.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Azathioprine is combined with Baricitinib.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Baricitinib.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Baricitinib.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Baricitinib.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Baricitinib.]
[A08AA11, lorcaserin, Lorcaserin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G04BD12, mirabegron, Mirabegron may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Carfilzomib is combined with Baricitinib.]
[V03AX03, cobicistat, The metabolism of Baricitinib can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Baricitinib can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Baricitinib can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Bosutinib is combined with Baricitinib.]
[L04AA31, teriflunomide, The serum concentration of Baricitinib can be increased when it is combined with Teriflunomide.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Abetimus is combined with Baricitinib.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Aldosterone is combined with Baricitinib.]
[D02BA02, octinoxate, Octinoxate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Baricitinib can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Bendamustine is combined with Baricitinib.]
[N04BD02, rasagiline, Rasagiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA29, tofacitinib, Baricitinib may increase the immunosuppressive activities of Tofacitinib.]
[V09IX04, fluorodeoxyglucose F18, Fludeoxyglucose (18F) may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V08CA11, gadofosveset, Gadofosveset trisodium may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EA05, ponatinib, The risk or severity of adverse effects can be increased when Ponatinib is combined with Baricitinib.]
[A16AX08, teduglutide, Teduglutide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A10BH04, alogliptin, Alogliptin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Glycerol phenylbutyrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Pomalidomide is combined with Baricitinib.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Baricitinib.]
[L03AA12, ancestim, Ancestim may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Everolimus is combined with Baricitinib.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Baricitinib can be increased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EE01, trametinib, Trametinib may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Florbetapir (18F) may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AX28, levomilnacipran, Levomilnacipran may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AJ03, dolutegravir, The serum concentration of Baricitinib can be increased when it is combined with Dolutegravir.]
[A10BJ03, lixisenatide, Lixisenatide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A05AA03, cholic acid, The serum concentration of Baricitinib can be increased when it is combined with Cholic Acid.]
[C02KX04, macitentan, Macitentan may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Ibrutinib is combined with Baricitinib.]
[N06AX26, vortioxetine, Vortioxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AP05, simeprevir, The metabolism of Baricitinib can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Sofosbuvir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05CH03, tasimelteon, Tasimelteon may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A16AA07, metreleptin, The metabolism of Baricitinib can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The risk or severity of adverse effects can be increased when Apremilast is combined with Baricitinib.]
[L02BG02, formestane, Formestane may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Baricitinib.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AC11, siltuximab, The risk or severity of adverse effects can be increased when Siltuximab is combined with Baricitinib.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Vedolizumab is combined with Baricitinib.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Belinostat is combined with Baricitinib.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Idelalisib is combined with Baricitinib.]
[N07XX08, tafamidis, The serum concentration of Baricitinib can be increased when it is combined with Tafamidis.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Baricitinib.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Decitabine is combined with Baricitinib.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Pirfenidone is combined with Baricitinib.]
[S03AA06, gentamicin, Baricitinib may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Blinatumomab is combined with Baricitinib.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Olaparib is combined with Baricitinib.]
[B01AF03, edoxaban, Edoxaban may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AC10, secukinumab, The risk or severity of adverse effects can be increased when Secukinumab is combined with Baricitinib.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Palbociclib is combined with Baricitinib.]
[L01EX08, lenvatinib, The serum concentration of Baricitinib can be increased when it is combined with Lenvatinib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Panobinostat is combined with Baricitinib.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Baricitinib.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, The serum concentration of Baricitinib can be increased when it is combined with Lansoprazole.]
[V03AB37, idarucizumab, Idarucizumab may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of adverse effects can be increased when Trabectedin is combined with Baricitinib.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Mepolizumab is combined with Baricitinib.]
[J02AC05, isavuconazole, The metabolism of Baricitinib can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Baricitinib.]
[L01XG03, ixazomib, Ixazomib may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M04AB05, lesinurad, Lesinurad may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N03AX23, brivaracetam, Brivaracetam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Ixekizumab is combined with Baricitinib.]
[L01XX52, venetoclax, The metabolism of Baricitinib can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, Bromazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Baricitinib may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C03CA02, bumetanide, The serum concentration of Baricitinib can be increased when it is combined with Bumetanide.]
[N01BB01, bupivacaine, Levobupivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Busulfan is combined with Baricitinib.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Baricitinib.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Brodalumab is combined with Baricitinib.]
[L01EF02, ribociclib, The metabolism of Baricitinib can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA36, ocrelizumab, The risk or severity of adverse effects can be increased when Baricitinib is combined with Ocrelizumab.]
[A06AH05, naldemedine, Naldemedine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Baricitinib may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[P01CA02, benznidazole, Baricitinib may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Baricitinib.]
[J01XX08, linezolid, The serum concentration of Baricitinib can be increased when it is combined with Linezolid.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Baricitinib can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, Baricitinib may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The risk or severity of adverse effects can be increased when Infliximab is combined with Baricitinib.]
[L01EX10, midostaurin, The metabolism of Baricitinib can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The excretion of Baricitinib can be decreased when combined with Brigatinib.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Sarilumab is combined with Baricitinib.]
[J01MA23, delafloxacin, Baricitinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Baricitinib is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Baricitinib.]
[L01XX59, enasidenib, The serum concentration of Baricitinib can be increased when it is combined with Enasidenib.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Vorinostat is combined with Baricitinib.]
[L01EM02, copanlisib, The excretion of Baricitinib can be decreased when combined with Copanlisib.]
[L01EF03, abemaciclib, The excretion of Baricitinib can be decreased when combined with Abemaciclib.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Baricitinib can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Baricitinib.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Baricitinib.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Budesonide is combined with Baricitinib.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AX18, letermovir, The serum concentration of Baricitinib can be increased when it is combined with Letermovir.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Acrivastine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L02BB05, apalutamide, The serum concentration of Baricitinib can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Baricitinib.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Baricitinib.]
[B02BX08, avatrombopag, The serum concentration of Baricitinib can be increased when it is combined with Avatrombopag.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Baricitinib.]
[S01AA13, fusidic acid, The metabolism of Baricitinib can be decreased when combined with Fusidic acid.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DD14, ceftibuten, The serum concentration of Baricitinib can be increased when it is combined with Ceftibuten.]
[J01GB14, plazomicin, Baricitinib may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[L01XX62, ivosidenib, The metabolism of Baricitinib can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The excretion of Baricitinib can be decreased when combined with Tafenoquine.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Baricitinib can be decreased when combined with Stiripentol.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[D08AE05, chloroxylenol, Chloroxylenol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA39, emapalumab, The risk or severity of adverse effects can be increased when Baricitinib is combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Baricitinib.]
[L01XJ03, glasdegib, The excretion of Baricitinib can be decreased when combined with Glasdegib.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Ravulizumab is combined with Baricitinib.]
[A06AX05, prucalopride, Prucalopride may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B01AC23, cilostazol, Cilostazol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Baricitinib is combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Baricitinib can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Baricitinib may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Baricitinib is combined with Cloprednol.]
[L04AB01, etanercept, The risk or severity of adverse effects can be increased when Etanercept is combined with Baricitinib.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Baricitinib is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Baricitinib is combined with Risankizumab.]
[J01DC04, cefaclor, The serum concentration of Baricitinib can be increased when it is combined with Cefaclor.]
[J01DB05, cefadroxil, The serum concentration of Baricitinib can be increased when it is combined with Cefadroxil.]
[J01DC03, cefamandole, The serum concentration of Baricitinib can be increased when it is combined with Cefamandole.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DB04, cefazolin, The serum concentration of Baricitinib can be increased when it is combined with Cefazolin.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EX15, pexidartinib, The excretion of Baricitinib can be decreased when combined with Pexidartinib.]
[J01DD12, cefoperazone, The serum concentration of Baricitinib can be increased when it is combined with Cefoperazone.]
[J01DD01, cefotaxime, The serum concentration of Baricitinib can be increased when it is combined with Cefotaxime.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DC07, cefotiam, The serum concentration of Baricitinib can be increased when it is combined with Cefotiam.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, The serum concentration of Baricitinib can be increased when it is combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The serum concentration of Baricitinib can be increased when it is combined with Ceftriaxone.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Baricitinib is combined with Upadacitinib.]
[L01EJ02, fedratinib, The excretion of Baricitinib can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Baricitinib can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The excretion of Baricitinib can be decreased when combined with Istradefylline.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DB01, cephalexin, The serum concentration of Baricitinib can be increased when it is combined with Cephalexin.]
[J01DB02, cephaloridine, The serum concentration of Baricitinib can be increased when it is combined with Cefaloridine.]
[J01DB03, cephalothin, The serum concentration of Baricitinib can be increased when it is combined with Cefalotin.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Baricitinib is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Baricitinib.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Baricitinib is combined with Diroximel fumarate.]
[N03AX25, cenobamate, The serum concentration of Baricitinib can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M09AX08, golodirsen, Baricitinib may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Dexpanthenol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XX72, tazemetostat, The excretion of Baricitinib can be decreased when combined with Tazemetostat.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Teprotumumab is combined with Baricitinib.]
[J05AE05, amprenavir, The metabolism of Baricitinib can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Baricitinib is combined with Ozanimod.]
[R02AA03, dichlorobenzyl alcohol, Baricitinib may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Dienogest may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Baricitinib.]
[C08CA16, clevidipine, Clevidipine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01BD07, dronedarone, The serum concentration of Baricitinib can be increased when it is combined with Dronedarone.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Baricitinib.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Baricitinib.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Baricitinib.]
[L01EX17, capmatinib, The excretion of Baricitinib can be decreased when combined with Capmatinib.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Fluprednidene is combined with Baricitinib.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V08CA05, mangafodipir, Mangafodipir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Baricitinib is combined with Inebilizumab.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Stepronin is combined with Baricitinib.]
[M09AX10, risdiplam, The serum concentration of Baricitinib can be increased when it is combined with Risdiplam.]
[L04AC19, satralizumab, The serum concentration of Baricitinib can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EX23, pralsetinib, The excretion of Baricitinib can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02BA03, choline salicylate, Baricitinib may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B06AC06, berotralstat, The metabolism of Baricitinib can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Baricitinib can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fludarabine is combined with Baricitinib.]
[M01AX25, chondroitin sulfates, Chondroitin sulfate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AJ04, cabotegravir, The serum concentration of Baricitinib can be increased when it is combined with Cabotegravir.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Voclosporin is combined with Baricitinib.]
[P03AX07, abametapir, The serum concentration of Baricitinib can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, The excretion of Baricitinib can be decreased when combined with Trilaciclib.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Baricitinib.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Baricitinib.]
[N02BG07, flupirtine, Flupirtine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Baricitinib is combined with Ponesimod.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Baricitinib.]
[A02BA01, cimetidine, The serum concentration of Baricitinib can be increased when it is combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XX73, sotorasib, The serum concentration of Baricitinib can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Baricitinib can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Baricitinib.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Baricitinib is combined with Pegcetacoplan.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Baricitinib is combined with Belumosudil.]
[P01CA03, fexinidazole, The serum concentration of Baricitinib can be increased when it is combined with Fexinidazole.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Baricitinib is combined with Anifrolumab.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AX25, St. John's wort extract, The metabolism of Baricitinib can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Baricitinib is combined with Ropeginterferon alfa-2b.]
[N01BB10, levobupivacaine, Levobupivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AA04, clomipramine, Clomipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01EB24, mavacamten, The serum concentration of Baricitinib can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Baricitinib is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Baricitinib is combined with Deucravacitinib.]
[N05AH02, clozapine, The metabolism of Baricitinib can be decreased when combined with Clozapine.]
[J01GB12, arbekacin, Baricitinib may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Baricitinib can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The risk or severity of adverse effects can be increased when Baricitinib is combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M04AC01, colchicine, Colchicine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01XB01, colistin, Baricitinib may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Baricitinib is combined with Leflunomide.]
[A04AA03, tropisetron, Tropisetron may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Nelarabine is combined with Baricitinib.]
[J01FA15, telithromycin, The metabolism of Baricitinib can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Ciclesonide is combined with Baricitinib.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C05BB03, invert sugar, Invert sugar may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V08AB05, iopromide, Iopromide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V08AB07, ioversol, Ioversol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V08AB12, ioxilan, Ioxilan may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J02AC02, itraconazole, The metabolism of Baricitinib can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The serum concentration of Baricitinib can be increased when it is combined with Acyclovir.]
[N05BA10, ketazolam, Ketazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Imatinib is combined with Baricitinib.]
[J02AC04, posaconazole, The metabolism of Baricitinib can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The serum concentration of Baricitinib can be increased when it is combined with Esomeprazole.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N07BC04, lofexidine, Lofexidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Magnesium carbonate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Meprednisone is combined with Baricitinib.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Melperone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Baricitinib.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Baricitinib.]
[S01XA18, cyclosporine, Baricitinib may increase the immunosuppressive activities of Cyclosporine.]
[C10AA07, rosuvastatin, The serum concentration of Baricitinib can be increased when it is combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Baricitinib can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Cytarabine is combined with Baricitinib.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Baricitinib.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Dactinomycin is combined with Baricitinib.]
[G03XA01, danazol, The metabolism of Baricitinib can be decreased when combined with Danazol.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Baricitinib.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N07BB05, nalmefene, Nalmefene may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Baricitinib can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Nicorandil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Baricitinib.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AA01, desipramine, Desipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Baricitinib.]
[V04CH02, indigo carmine, Indigotindisulfonic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Baricitinib.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Baricitinib.]
[L04AB04, adalimumab, The risk or severity of adverse effects can be increased when Adalimumab is combined with Baricitinib.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R05DA08, pholcodine, Pholcodine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The serum concentration of Baricitinib can be increased when it is combined with Diclofenac.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Ixabepilone is combined with Baricitinib.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Pirarubicin is combined with Baricitinib.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, The metabolism of Baricitinib can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Difluocortolone is combined with Baricitinib.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01AA05, digoxin, Baricitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Baricitinib.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Baricitinib.]
[J05AE08, atazanavir, The metabolism of Baricitinib can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, Potassium perchlorate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C08DB01, diltiazem, The metabolism of Baricitinib can be decreased when combined with Diltiazem.]
[V03AB09, dimercaprol, Dimercaprol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Dimethyl sulfoxide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G02AD02, dinoprostone, The serum concentration of Baricitinib can be increased when it is combined with Dinoprostone.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Sirolimus is combined with Baricitinib.]
[S01AX06, resorcinol, Resorcinol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Baricitinib is combined with Natalizumab.]
[S02AA12, rifamycin SV, The metabolism of Baricitinib can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Baricitinib can be increased when combined with Rifapentine.]
[R06AE09, levocetirizine, Levocetirizine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Baricitinib.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EX01, sunitinib, The risk or severity of adverse effects can be increased when Sunitinib is combined with Baricitinib.]
[A04AD12, aprepitant, The metabolism of Baricitinib can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Baricitinib.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01EB18, ranolazine, The excretion of Baricitinib can be decreased when combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AA12, doxepin, Doxepin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Doxorubicin is combined with Baricitinib.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A08AA10, sibutramine, Sibutramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A12CA02, sodium sulfate, Sodium sulfate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Corticotropin is combined with Baricitinib.]
[J01CG02, tazobactam, The serum concentration of Baricitinib can be increased when it is combined with Tazobactam.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Temozolomide is combined with Baricitinib.]
[M01AC02, tenoxicam, The serum concentration of Baricitinib can be increased when it is combined with Tenoxicam.]
[C09AA02, enalapril, The serum concentration of Baricitinib can be increased when it is combined with Enalapril.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AG03, toloxatone, Toloxatone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Chloral hydrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Trilostane is combined with Baricitinib.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Baricitinib is combined with Trofosfamide.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Baricitinib.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C08CA12, mepirodipine, The metabolism of Baricitinib can be decreased when combined with Barnidipine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Baricitinib.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Carboplatin is combined with Baricitinib.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02CA02, ergotamine, The metabolism of Baricitinib can be decreased when combined with Ergotamine.]
[L03AX05, pidotimod, Pidotimod may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Baricitinib can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Estazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A02BC02, pantoprazole, The serum concentration of Baricitinib can be increased when it is combined with Pantoprazole.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Estramustine is combined with Baricitinib.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Baricitinib can be increased when it is combined with Conjugated estrogens.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Baricitinib.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Baricitinib is combined with Fluticasone.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01CB01, etoposide, The risk or severity of adverse effects can be increased when Etoposide is combined with Baricitinib.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Baricitinib.]
[R06AX12, terfenadine, The metabolism of Baricitinib can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Baricitinib can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Baricitinib.]
[C10AA03, pravastatin, The serum concentration of Baricitinib can be increased when it is combined with Pravastatin.]
[M01CB01, gold sodium thiomalate, Sodium aurothiomalate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B05AA05, dextran, Dextran may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Baricitinib.]
[A02BA03, famotidine, The serum concentration of Baricitinib can be increased when it is combined with Famotidine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01EE01, latanoprost, The serum concentration of Baricitinib can be increased when it is combined with Latanoprost.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Baricitinib.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Baricitinib.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G04BD02, flavoxate, Flavoxate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Baricitinib can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Flucytosine is combined with Baricitinib.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Baricitinib.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluocinonide is combined with Baricitinib.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Fluocortolone is combined with Baricitinib.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Baricitinib.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Baricitinib.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Baricitinib.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01BC03, tegafur, Tegafur may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AE10, darunavir, The metabolism of Baricitinib can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The serum concentration of Baricitinib can be increased when it is combined with Furosemide.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AD09, ganciclovir, The serum concentration of Baricitinib can be increased when it is combined with Ganciclovir.]
[C10AB04, gemfibrozil, The serum concentration of Baricitinib can be increased when it is combined with Gemfibrozil.]
[J01XA03, telavancin, Telavancin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Dasatinib is combined with Baricitinib.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01EX02, sorafenib, The risk or severity of adverse effects can be increased when Sorafenib is combined with Baricitinib.]
[M01CB04, aurothioglucose, Aurothioglucose may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Baricitinib.]
[N05AH04, quetiapine, Quetiapine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06BX13, idebenone, Idebenone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Irinotecan is combined with Baricitinib.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G03DC01, allylestrenol, Allylestrenol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Baricitinib.]
[C08CA10, nilvadipine, The metabolism of Baricitinib can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C02DB02, hydralazine, Hydralazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Baricitinib may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G04BD06, propiverine, Baricitinib may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Baricitinib.]
[B05AA07, hetastarch, Hydroxyethyl Starch may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Baricitinib.]
[R02AX02, ibuprofen, The serum concentration of Baricitinib can be increased when it is combined with Ibuprofen.]
[B05XA08, sodium acetate, Sodium acetate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Baricitinib.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Ifosfamide is combined with Baricitinib.]
[N06AA02, imipramine, Imipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Paclitaxel is combined with Baricitinib.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Tixocortol is combined with Baricitinib.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Topotecan is combined with Baricitinib.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The serum concentration of Baricitinib can be increased when it is combined with Indomethacin.]
[A11HA07, inositol, Baricitinib may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Baricitinib.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Baricitinib.]
[N06AX17, milnacipran, The metabolism of Baricitinib can be decreased when combined with Milnacipran.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Eculizumab is combined with Baricitinib.]
[A10BH01, sitagliptin, Sitagliptin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Baricitinib.]
[V03AB01, ipecac, Baricitinib may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[J04AC01, isoniazid, The metabolism of Baricitinib can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Baricitinib may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AA24, kanamycin, Baricitinib may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The risk or severity of adverse effects can be increased when Tocilizumab is combined with Baricitinib.]
[N01AX03, ketamine, Ketamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B01AC22, prasugrel, Prasugrel may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J02AB02, ketoconazole, The metabolism of Baricitinib can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Baricitinib can be decreased when combined with Levoketoconazole.]
[M02AA10, ketoprofen, The serum concentration of Baricitinib can be increased when it is combined with Ketoprofen.]
[L04AA24, abatacept, The risk or severity of adverse effects can be increased when Abatacept is combined with Baricitinib.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Baricitinib.]
[S01AA21, amikacin, Baricitinib may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Lomustine is combined with Baricitinib.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Baricitinib can be decreased when combined with Lovastatin.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Temsirolimus is combined with Baricitinib.]
[B05XA11, magnesium chloride, Magnesium chloride may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Pralatrexate is combined with Baricitinib.]
[L01EA03, nilotinib, The metabolism of Baricitinib can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Baricitinib.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, The serum concentration of Baricitinib can be increased when it is combined with Melatonin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Melphalan is combined with Baricitinib.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G04BX16, tiopronin, Tiopronin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Paliperidone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A10BA02, metformin, The excretion of Baricitinib can be decreased when combined with Metformin.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Baricitinib can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Baricitinib.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AX03, methotrexate, The serum concentration of Baricitinib can be increased when it is combined with Methotrexate.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V04CG05, methylene blue, The excretion of Baricitinib can be decreased when combined with Methylene blue.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Baricitinib.]
[G03EK01, methyltestosterone, The excretion of Baricitinib can be increased when combined with Methyltestosterone.]
[A03FA01, metoclopramide, Metoclopramide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S02AA13, miconazole, The metabolism of Baricitinib can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01AA08, minocycline, The serum concentration of Baricitinib can be increased when it is combined with Minocycline.]
[L01XX23, mitotane, The metabolism of Baricitinib can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Baricitinib.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Baricitinib.]
[C01BD01, amiodarone, The metabolism of Baricitinib can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Baricitinib.]
[G04BA01, ammonium chloride, Ammonium chloride may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Ofatumumab is combined with Baricitinib.]
[L01EX03, pazopanib, The risk or severity of adverse effects can be increased when Pazopanib is combined with Baricitinib.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Baricitinib.]
[N03AB05, fosphenytoin, The metabolism of Baricitinib can be increased when combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Baricitinib.]
[C07AA12, nadolol, The excretion of Baricitinib can be decreased when combined with Nadolol.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V03AB15, naloxone, The metabolism of Baricitinib can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The risk or severity of adverse effects can be increased when Anakinra is combined with Baricitinib.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Docetaxel is combined with Baricitinib.]
[S03AA01, neomycin, Baricitinib may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L03AX16, plerixafor, Plerixafor may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AA23, netilmicin, Baricitinib may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Baricitinib can be decreased when combined with Desvenlafaxine.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Baricitinib.]
[C08CA04, nicardipine, The metabolism of Baricitinib can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, Nifedipine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AC04, rilonacept, The risk or severity of adverse effects can be increased when Rilonacept is combined with Baricitinib.]
[N02AA02, opium, Opium may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C01AC01, ouabain, The serum concentration of Baricitinib can be increased when it is combined with Ouabain.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01AA04, oxytetracycline, The serum concentration of Baricitinib can be increased when it is combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The serum concentration of Baricitinib can be increased when it is combined with Aminohippuric acid.]
[J04AB30, capreomycin, Baricitinib may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Paramethasone is combined with Baricitinib.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[G04BD11, fesoterodine, Fesoterodine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C07AA23, penbutolol, Penbutolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Penicillamine is combined with Baricitinib.]
[S01AA14, penicillin G, The serum concentration of Baricitinib can be increased when it is combined with Benzylpenicillin.]
[J01CE09, penicillin G procaine, Procaine benzylpenicillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Baricitinib.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Baricitinib.]
[N05CA01, pentobarbital, The metabolism of Baricitinib can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Baricitinib.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Baricitinib.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N03AA02, phenobarbital, The metabolism of Baricitinib can be increased when combined with Phenobarbital.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M02AA01, phenylbutazone, The serum concentration of Baricitinib can be increased when it is combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Baricitinib can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The risk or severity of adverse effects can be increased when Golimumab is combined with Baricitinib.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Baricitinib can be decreased when combined with Saquinavir.]
[N06BX03, piracetam, Piracetam may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S01BC06, piroxicam, The serum concentration of Baricitinib can be increased when it is combined with Piroxicam.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AG02, delavirdine, The metabolism of Baricitinib can be decreased when combined with Delavirdine.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L04AC08, canakinumab, The risk or severity of adverse effects can be increased when Canakinumab is combined with Baricitinib.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Baricitinib can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, Saxagliptin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Prednisolone is combined with Baricitinib.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Baricitinib.]
[P01BA03, primaquine, The metabolism of Baricitinib can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Baricitinib can be increased when combined with Primidone.]
[M04AB01, probenecid, The serum concentration of Baricitinib can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, The excretion of Procainamide can be decreased when combined with Baricitinib.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Procarbazine is combined with Baricitinib.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[R06AD02, promethazine, Promethazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Baricitinib.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[B01AC09, epoprostenol, Epoprostenol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N07XX07, dalfampridine, Dalfampridine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[P02CC01, pyrantel, Pyrantel may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Baricitinib.]
[P01BD01, pyrimethamine, The excretion of Baricitinib can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, The serum concentration of Baricitinib can be increased when it is combined with Quinidine.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J04AB02, rifampin, The serum concentration of Baricitinib can be increased when it is combined with Rifampicin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Baricitinib.]
[S01BC08, salicylic acid, The serum concentration of Baricitinib can be increased when it is combined with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Baricitinib.]
[J01GB08, sisomicin, Baricitinib may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Sodium fluoride may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Baricitinib.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[L01CD04, cabazitaxel, The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Baricitinib.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Baricitinib.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Baricitinib.]
[V09AB03, ioflupane I-123, Ioflupane I-123 may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Technetium Tc-99m exametazime may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Florbetaben (18F) may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[N03AG01, valproic acid, The serum concentration of Baricitinib can be increased when it is combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Baricitinib is combined with Hydrocortisone butyrate.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
